Clinical Trials Results - National Cancer Institute

Skip to content

National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -10 of 115 Show results per page	View Search Criteria \| Help With Results


Sort By:	Version:	Format:


1.		Prostate Cancer Study In Men Who Have Failed First-Line Androgen Deprivation Therapy

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase IV				Treatment				Active				40 to 90				Pharmaceutical / Industry				AVO108943 NCT00470834


2.		Ablatherm Integrated Imaging High Intensity Focused Ultrasound for the Indication of Low Risk, Localized Prostate Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Treatment				Active				50 and over				Other				G050103 NCT00295802


3.		Phase III Randomized Trial of Suicide Gene Therapy and Prostate Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Treatment				Active				18 and over				Other				Prostate4809 P01 CA098012, NCT00583492

First Published: 10/1/2008


4.		Phase II/III Randomized Study of Adjuvant Soy Protein Isolate in Preventing Recurrence in Patients Who Have Undergone Radical Prostatectomy for Stage II Prostate Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Biomarker/Laboratory analysis, Treatment				Active				40 to 75				NCI				UIC-2006-0706 2006-0706, NCT00765479

Last Modified: 1/14/2009 First Published: 6/23/2003


5.		Phase III Randomized Study of Interstitial Brachytherapy With or Without External Beam Radiotherapy in Patients With Intermediate-Risk Prostate Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Active				18 and over				NCI				RTOG-0232 CTSU, NCT00063882

Last Modified: 5/27/2008 First Published: 5/28/2004


6.		Phase III Randomized Study of Intensity-Modulated Radiotherapy With Versus Without Dose Sparing For Erectile Tissue in Patients With Stage T1b-T2c Adenocarcinoma of the Prostate

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Supportive care, Treatment				Active				Not specified				NCI				FCCC-03028 NCT00084552


7.		Hormone Suppression and Radiation Therapy for 6 Months With/Without Docetaxel for High Risk Prostate Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Active				30 and over				Other				05-043 NCT00116142


8.		Study of Sildenafil Citrate During and After Radiotherapy/Hormone Therapy for Erectile Function Versus Radiotherapy/Hormone Therapy for Prostate Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Supportive care, Treatment				Active				Not specified				Other				05-007 NCT00142506


9.		Chemotherapy After Prostatectomy (CAP) For High Risk Prostate Carcinoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Active				Not specified				Other				553 NCT00132301


10.		Low Dose Supplemental External Radiation With pd-103 vs pd-103 Alone for Prostate Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Active				40 to 80				Other				04-8-10 NCT00241384

Select All on One Page


					1 2 3 4 Next >

| | | | | | | |

A Service of the National Cancer Institute